講師介紹

< 回列表
黃偉謙
  • Director, Cancer Biology and Precision Therapeutic Center, China Medical University, Taichung, Taiwan
  • Research Fellow and Deputy Director, Center for Molecular Medicine, China Medical University Hospital, Taichung, Taiwan
  • Chairman, Program for Cancer Biology and Drug Discovery, China Medical University, Taichung, Taiwan
  • Professor, Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan
  • Professor, School of Pharmacy, China Medical University, Taichung, Taiwan
Ta-Cheng Tung’s Basic Cancer Research Award 董大成博士癌症基礎醫學研究傑出獎頒獎暨專題演講
角色 講師
日期時間 05/03 09:35 - 10:10
地點 701A
學歷 / 訓練
2004, PhD., Department of Pharmacology, College of Medicine, National Taiwan University, Taipei, Taiwan.
2000, M.S., Department of Pharmacology, College of Medicine, National Cheng-Kung University, Tainan, Taiwan.
專業與研究經歷
2017 - 2022, Associate Dean, the Department of Research & Development, China Medical University, Taichung, Taiwan
2016 - 2017, Director, Administration of the Department of Research & Development, China Medical University, Taichung, Taiwan
2006 - 2008, Postdoc, Department of Molecular and Cellular Oncology, UT. M.D. Anderson Cancer Center, Houston, TX, USA
2004 - 2006, Postdoc, Department of Pharmacology, College of Medicine, National Taiwan University
獲獎與榮譽
2025 Breast Cancer Outstanding Research Paper Award, Taiwan Breast Cancer Foundation.
2025 National Innovation Award
2025 National Science and Technology Council Innovation and Entrepreneurship Incentive Program – Acer Legacy Award
2024 Potential Team of New Drug Development, Pitch Day, National Biotechnology Research Park.
2012 Teacher Award for Outstanding Teaching Performance, College of Medicine, China Medical University
重要出版品
  • 1 Huang H.Y., Huang Y.-Y., Wu C.-L., Huang W.-C.#, Lai C.-L.# (2026, Jan). Smog, Sugar, and Synapses: Unraveling the PM2.5-Insulin Resistance-Alzheimer's Disease Axis. Redox Biology, 90:104031.
  • 2 Hu D.-W., Huang C.-H., He Y.-H., Wei Y-L., Hu S.-W., Cheng F.-J., Huynh T.K., Chen, B.-R., Wang B.-W., Lee D.-Y., Yeh M.-H., Chang Y.-J., Liu L.-C., Hung M.-C., and Huang W.-C.#. SLC6A14 Drives Mitochondrial Fusion and Oxidative Phosphorylation to Promote Cancer Stemness and Early-Onset of Breast Cancer. Advanced Science 2025. Sep 17:e10811.
  • 3 Hu S.-W., Yeh M.-H., He Y.-H., Wei Y-L., Cheng F.-J., Yeh Y.-L., Huynh T.K., Liu P.-T., Hu D.-W., Chang T. -H., Wang B.-W., Chen, B.-R., Lin M.-C., Lee D.-Y., Hsieh Y.-H., Hsu Y.-M., Tang C.-H., Ho P.-C., Hung M.-C., and Huang W.-C.# Co-targeting CDK4/6 enhances anti-cancer activity and alleviates immune-related adverse event of anti-PD-1 antibody for Breast Cancer. Cell Report Medicine 2025. Oct 30:102429.
  • 4 Hsu S.-C., He Y.-H., Chen Y.-J., Phuong U.L.N., Liu P.-T., Liu P.T., Huynh T. K., Chen Y.L., Wei Y.-L., Chou H.C., Huang W.-C.,# Jeng L.-B. Disrupting DDB2–DNA Interaction by Lapatinib Enhances Chemotherapy Sensitivity. International Journal of Biological Sciences 2025. 21(14):6007-6024.
  • 5 Huang H.-Y., Chen C.-H., Cheng F.-J., Wang B.-W., Tu C.-Y., Chen Y.-J., He Y.-H.#, Yao C.-H.#, and Huang W.-C.# Incense-burning smoke ingredient Auramine enhances lincRNA-p21 expression for chemosensitization in p53-mutated non-small cell lung cancer. Journal of Hazardous Materials. 2024 Sep 15:477:135105.